Introduction
Over the past decades, chronic disseminated candidiasis (CDC) has been recognized as a distinct subset of invasive fungal infections (IFI), affecting immunocompromised individuals, in particular neutropenic patients suffering from hematological malignancies [1] . CDC predominantly involves the liver, spleen and occasionally the kidneys and other organs [2] , with children especially at risk for this form of infection [3] . Diagnosis of CDC is cumbersome because of the nonspecifi c symptoms and the lack of positive blood cultures [1, 2] . Imaging modalities like ultrasonography, computed tomography (CT)-scans and magnetic resonance imaging (MRI) may be helpful diagnostic tools. However, the lack of an infl ammatory response microbiology laboratory within 8 hours of being collected from the patients. A Blankophor P stain was used for microscopic examination using a fl uorescence microscope. The samples were cultured on Sabouraud agar and in liquid Sabouraud medium and incubated at 29 ° C. Fungi isolated in cultures were identifi ed based on the colony morphology and ability to produce germ tubes. In germ tube negative isolates the Auxacolor system was employed (Biorad Laboratories, Marnes-La-Coquette, France). Samples that did not yield growth were investigated with a Candida -specifi c 18S rRNA gene-targeted PCR assay as described previously [13] . Cultures of the liver biopsy material from two patients yielded C. albicans establishing the diagnosis of CDC. However, liver biopsy materials from the other two patients proved to be negative in culture. Probable CDC was diagnosed in these patients by PCR studies of liver tissue which revealed C. albicans (patient 2) and by fl uorescence microscopy showing yeasts in the spleen biopsy (patient 3). Time between onset of neutropenic fever and establishing CDC ranged from 20 -49 days. Diagnosis of proven, probable or possible IFI was made according to the European Organization for Research and Treatment of Cancer and Mycoses Study Group (EORTC/MSG) [14] . After diagnosis of CDC, all patients were continued on antifungal treatment. As appropriate therapy for CDC is not well established, the choice of antifungal agent was based on the experience of the treating physician and on the clinical condition of the patient. During the period that the children were seriously ill, caspofungin was chosen because of its broad antifungal effi cacy against both Candida and Aspergillus species. After partial recovery, all patients were switched to azole antifungals. Antileukemic therapy was not or only shortly interrupted in three patients. Treatment was adapted in order to avoid subsequent episodes of neutropenia. In patient 4, antineoplastic treatment was interrupted for 5.5 months because of a poor clinical condition due to the seriously complicated clinical course. Patient 1 and 2 continued antifungal therapy for 3 months after completing chemotherapy, patient 3 and 4 stopped antifungal therapy when started on maintenance Patient 1, 2 and 3 were in hematological remission 1 month after the start of treatment. In patient 4, the mediastinal mass had diminished substantially in size after 1 week of treatment with corticosteroids.
All patients developed neutropenic fever during induction therapy and received broad spectrum antibiotics and empirical antifungal treatment. In patient 1, Staphylococcus epidermidis was isolated in blood culture. In patient 4, fever was initially attributed to a severe systemic Varicella infection resulting in acute respiratory distress syndrome (ARDS), liver failure and a hepatic encephalopathy. S. epidermidis and Candida albicans were later isolated in blood culture. However, fever persisted despite antibacterial, antiviral and antifungal therapy in both patients 1 and 4.
All patients developed gastro-intestinal symptoms with marked abdominal distension, hepato(spleno)megaly, melena (two patients) and icterus (one patient). The course was further complicated by respiratory insuffi ciency due to mechanical pressure of the enlarged liver and spleen, which resulted in the use of artifi cial ventilation in two patients. While a diagnostic work-up for pulmonary aspergillosis was performed in all patients, which included galactomannan serology, High Resolution Computed Tomography (HRCT) scan of the thorax and bronchoalveolar lavage in two patients the diagnosis could not be established. Because of the gastro-intestinal symptoms, abdominal ultrasound was performed for three patients. Two were neutropenic at that time and abdominal ultrasound showed no abnormalities apart from hepatosplenomegaly. In the 3rd patient without neutropenia, multiple lesions were observed in the spleen, while abdominal CT showed extensive lesions in liver, spleen and kidneys. In patient 4, a PET/CT scan was performed because of ongoing fever, which showed inhomogeneous liver lesions.
Invasive diagnostic procedures were performed for all patients which included a liver biopsy (patient 1 and 2), liver puncture (patient 4) and a spleen biopsy (patient 3) because of persisting fever and gastro-intestinal symptoms in combination with radiologic abnormalities in two patients. The patient samples were processed in the 
Discussion
CDC is a potentially lethal complication encountered in the febrile neutropenic host treated with intensive chemotherapy for hematological malignancy. The reported frequency of CDC ranges between 3 and 29% [9] . Limited data exist on the incidence of invasive fungal infections (IFI) and in particular CDC in children. Kaya et al . found an overall incidence of 13.6 % and 1.3% for IFI and CDC, respectively, in children with leukemia. Incidence of IFI was twice as common in AML (20.7%) compared to ALL (10.7%) [15] . Prevalence of CDC in our pediatric population during the study period was four out of 86 ALL patients and seven T-cell NHL patients, resulting in an incidence of 4.3% in this patient group. Prolonged neutropenia and neutrophil dysfunction as a result of immunosuppressive therapy, e.g., corticosteroids are independent risk factors for CDC [3] . Therefore, CDC is rare in patients treated for solid tumors [16] . The use of steroids in the induction chemotherapy for both ALL and NHL was a risk factor for CDC in our patients. The diagnosis of CDC is cumbersome to establish because, as far as we know, there are no standardized guidelines available for its diagnosis. The time between onset of neutropenic fever and the diagnosis of CDC ranged from 20 -49 days in our patients, demonstrating the diffi culty in the early establishment of the presence CDC. C. albicans was cultured from the blood samples of only one patient, underscoring the reported low sensitivity of this procedure [17] . As shown in patients 1 and 2, the drawbacks of imaging modalities in diagnosing CDC is the diffi culty in visualizing fungal lesions during the neutropenic phase because of the lack of infl ammatory response essential to form an infi ltrate [4, 9] . Repeating the studies after recovery of the neutrophil count might improve the diagnostic accuracy of radiological techniques. Among the imaging modalities, MRI appears to be superior to both CT and ultrasound [18] . Since MRI was not performed in our patients, it remains unclear if we could have made an earlier diagnosis with this imaging method.
All patients underwent a biopsy or puncture of the liver or spleen to establish the diagnosis of CDC. In two patients, culture of the biopsy material remained negative, possibly because they had received empirical antifungal treatment. Diagnosis could be made by PCR and direct fl uorescence microscopy, respectively.
The disadvantage of performing a liver or spleen biopsy is the invasiveness of the procedure and the risk of bleeding complications in patients with co-existing coagulopathy. Therefore, newer non-invasive detection methods, like Candida antigen (mannan) and Candida antibody (anti-mannan) are under investigation. The results of studies in adults assessing the value of mannan (Ma) and anti-mannan antibodies (Ma-Ab) in serum are promising, indicating that it is a sensitive technique by which the median time to diagnosis of CDC could be signifi cantly shortened [19] .
The optimal management of CDC is not well established. Prolonged therapy with lipid formulations or conventional amphotericin B has been regarded as fi rst line treatment [9] . However, fl uconazole or the newer triazoles, as well as the echinocandins might be as effi cacious as amphotericin B with fewer side effects [5 -8] .
A controversial issue is whether CDC requires discontinuation of chemotherapy, rendering the patients vulnerable to progression or relapse of the underlying malignancy. Because the prognosis of patients with CDC is directly related to the underlying malignancy, prolonged interruption of antineoplastic therapy is not desirable. Clinical data of CDC in adults does not preclude further chemotherapy [9] . The limited experience in our patients indicates that this also applies to children.
The scarce data available in the literature on the mortality of CDC in patients with cancer range from 10 -62 % [17, 20] . Pediatric investigations demonstrate a mortality of 33% to 60% in children with CDC [21, 22] . The favorable course in our patients might be infl uenced by the underlying malignancy, as none of our patients had AML or relapsed ALL, which are well known for their increased risk of IFI.
In conclusion, CDC leads to signifi cant morbidity and mortality in children diagnosed with hematological malignancies. Neutropenic fever not responding to conventional antibiotics in combination with abdominal distension and hepatosplenomegaly should raise the suspicion of CDC. Early diagnosis is a major challenge since imaging modalities and laboratory studies often fail to demonstrate CDC in the neutropenic patient. Therefore it is advisable to repeat the radiological studies when neutropenia has recovered, especially when there is a high suspicion of CDC. Continuation of chemotherapy is feasible and recommended during treatment for CDC in order to prevent progression or relapse of the underlying malignancy.
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